An experimental AIDS vaccine made from two failed products has protected people for the first time, reducing the rate of infection by about 30 percent, researchers said on Thursday.
Developers said they were now debating how to test the limited amounts of vaccine they have left to find out if there are ways to make it work better.
Scientists said they were unsure how or why the vaccines worked when used together in the trial, which took place in Thailand, and will study the volunteers to find out.
All agreed that a commercial product would be years away, but the WHO said the result created new hope that an effective vaccine would eventually be found.
“The result of the study is a very important step for developing an AIDS vaccine,” Thai Health Minister Withaya Kaewparadai told a news conference in Bangkok. “It’s the first time in the world that we have found a vaccine that can prevent HIV infection.”
Activists and researchers alike were thrilled.
“The outcome is very exciting news and a significant scientific achievement,” said Seth Berkley, chief executive officer of the International AIDS Vaccine Initiative, which was not involved in this study. “It’s the first demonstration that a candidate AIDS vaccine provides benefit in humans.”
The vaccine is a combination of Sanofi-Pasteur’s ALVAC canary pox/HIV vaccine and the failed HIV vaccine AIDSVAX, made by a San Francisco firm called VaxGen and now owned by the nonprofit Global Solutions for Infectious Diseases.
The trial was sponsored by the US government and conducted by the Thai Ministry of Public Health. It cut the risk of infection by 31.2 percent among 16,402 volunteers over three years.
“We had 74 infections in the placebo group and 51 in the vaccine group,” said Jerome Kim, a US colonel at the Walter Reed Army Institute of Research in Maryland, who helped lead the trial.
The results were a triumph for supporters, who went ahead with the giant trial despite criticism it was unethical or a waste of money because the vaccine was widely expected to have no effect.
The AIDS virus infects an estimated 33 million people globally and has killed 25 million since it was identified in the 1980s. It affects immune cells called T-cells.
Cocktails of drugs can control HIV but there is no cure. In 2007, Merck ended a trial of its vaccine after it was found not to work, and in 2003, AIDSVAX used alone was found to offer no protection.
The WHO and the Joint United Nations Program on HIV/AIDS stressed the effects of the vaccine in the Thailand test were modest.
“However, these results have instilled new hope in the HIV vaccine research field and promise that a safe and highly effective HIV vaccine may become available for populations throughout the world who are most in need of such a vaccine,” they said.
“What is needed here is more in-depth analysis,” Sanofi’s Jim Tartaglia told a briefing.
Donald Francis of Global Solutions for Infectious Diseases said the companies had limited amounts of vaccine left to test and would have to make more.
“For me the biggest question is, how do you take what we know of this vaccine and give it greater protective power. Once you know that, then it makes sense to go to other parts of a population,” Sanofi’s Chris Viehbacher said.
POLITICAL PRISONERS VS DEPORTEES: Venezuela’s prosecutor’s office slammed the call by El Salvador’s leader, accusing him of crimes against humanity Salvadoran President Nayib Bukele on Sunday proposed carrying out a prisoner swap with Venezuela, suggesting he would exchange Venezuelan deportees from the US his government has kept imprisoned for what he called “political prisoners” in Venezuela. In a post on X, directed at Venezuelan President Nicolas Maduro, Bukele listed off a number of family members of high-level opposition figures in Venezuela, journalists and activists detained during the South American government’s electoral crackdown last year. “The only reason they are imprisoned is for having opposed you and your electoral fraud,” he wrote to Maduro. “However, I want to propose a humanitarian agreement that
ECONOMIC WORRIES: The ruling PAP faces voters amid concerns that the city-state faces the possibility of a recession and job losses amid Washington’s tariffs Singapore yesterday finalized contestants for its general election on Saturday next week, with the ruling People’s Action Party (PAP) fielding 32 new candidates in the biggest refresh of the party that has ruled the city-state since independence in 1965. The move follows a pledge by Singaporean Prime Minister Lawrence Wong (黃循財), who took office last year and assumed the PAP leadership, to “bring in new blood, new ideas and new energy” to steer the country of 6 million people. His latest shake-up beats that of predecessors Lee Hsien Loong (李顯龍) and Goh Chok Tong (吳作棟), who replaced 24 and 11 politicians respectively
Archeologists in Peru on Thursday said they found the 5,000-year-old remains of a noblewoman at the sacred city of Caral, revealing the important role played by women in the oldest center of civilization in the Americas. “What has been discovered corresponds to a woman who apparently had elevated status, an elite woman,” archeologist David Palomino said. The mummy was found in Aspero, a sacred site within the city of Caral that was a garbage dump for more than 30 years until becoming an archeological site in the 1990s. Palomino said the carefully preserved remains, dating to 3,000BC, contained skin, part of the
Russian hackers last year targeted a Dutch public facility in the first such an attack on the lowlands country’s infrastructure, its military intelligence services said on Monday. The Netherlands remained an “interesting target country” for Moscow due to its ongoing support for Ukraine, its Hague-based international organizations, high-tech industries and harbors such as Rotterdam, the Dutch Military Intelligence and Security Service (MIVD) said in its yearly report. Last year, the MIVD “saw a Russian hacker group carry out a cyberattack against the digital control system of a public facility in the Netherlands,” MIVD Director Vice Admiral Peter Reesink said in the 52-page